The General Assembly of ISMAAP in conference
ISMAAP meeting in Graz/Austria
Eight countries share information to improve patient care
From 5th until 8th of Oct. 2006 ISMAAP held its last meeting of the year in Graz. Unfortunately not all the countries were able to attend. However, it was a good opportunity to review the progress made over the year and plan for 2007.
Following on from the success of the symposium at the World Heart Congress in Barcelona it was decided to hold author one at the “International Society of Thrombosis and Haemostasis (ISTH) in Geneva in July 2007.
Funding is still being sought in order to produce information for people who travel in Europe about the differences between the anticoagulation drugs prescribed and where they can find help if they need I while abroad.
It is also hoped that a major survey of patients across Europe will be conducted via the respective countries web sites this year to find out how anticoagulation therapy effects people, and what are the similarities between patients in the difference countries.
Dr. Koertke –medical advisor of ISMAAP – has recently published the results of a follow up study to the ESCAT trial. The paper is titled “Self-Management of oral anticoagulation therapy improves long term survival in patient with mechanical heart valve replacement”.
In his talk Michael Knight (AnticoagulationEurope) refers to the success that INR self-management becomes more popular in United Kingdom.
The question why the therapeutic INR values are varying in Europe was discussed between the members of ISMAAP and physicians.
The coming up ISMAAP meeting will take place October 2007 in Salzburg.
Michael Knight/C.Schaefer (Feb.2007)
Below: PD Dr. med. Koertke explains the reason why therapeutic INR values are varying.
